logo
Scientists produced world's first kangaroo embryo through IVF. It has sparked hope for marsupial conservation

Scientists produced world's first kangaroo embryo through IVF. It has sparked hope for marsupial conservation

CNN08-02-2025

Scientists in Australia have successfully produced the world's first kangaroo embryo through in vitro fertilization, or IVF, a feat they hailed as a 'ground-breaking achievement' that could one day help save endangered species.
The research could be pivotal for Australia's conservation efforts, given the country's urgent need to protect its endemic species after having one of the world's worst extinction records.
Australia has lost at least 33 mammal species since European settlement of the already inhabited continent, according to Australian non-profit Invasive Species Council, a higher rate of extinction than other continent on Earth in recent history.
While the eastern grey kangaroos used in this trial are not endangered, many of Australia's marsupial species are, including koalas and Tasmanian devils.
Scientists at the University of Queensland first assessed how kangaroo eggs and sperm developed in a laboratory, before injecting a single sperm directly into a mature egg, using a technique known as intracytoplasmic sperm injection, the university said Thursday.
Andres Gambini, who led the research into the kangaroo embryo, said the technique could be applied to other animals under the threat of extinction.
'Our ultimate goal is to support the preservation of endangered marsupial species like koalas, Tasmanian devils, northern hairy-nosed wombats and Leadbeater's possums,' he said, referring to mammals that carry their young in pouches and are an iconic feature of Australia's unusual fauna.
'Access to marsupial tissues is challenging as they are less studied than domestic animals despite being iconic and integral to Australian biodiversity,' he added.
In 2022, the Australian government announced a 10-year plan to eliminate further extinctions, which included efforts to conserve more than 30% of land mass and protect 110 priority species across the country.
More than 2,200 species and ecosystems in Australia are classified as threatened with extinction, according to a 2023 report by non-profit Australian Conservation Foundation.
CNN's Jay Ganglani contributed reporting.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ancient Romans snacked on deep-fried songbirds
Ancient Romans snacked on deep-fried songbirds

Yahoo

time3 hours ago

  • Yahoo

Ancient Romans snacked on deep-fried songbirds

Fast food didn't start with McDonald's—quick, convenient meals have been a dietary staple of busy societies for millennia. Across the Roman empire, roadside shops known as popinae and tabernae often served up inexpensive, affordable dishes to hungry locals and travelers alike. But after scouring ancient garbage piles near one such popina in Mallorca, Spain, archeologists are better understanding how certain entrées transcended class divisions more often than previously thought. According to findings recently published in the International Journal of Osteoarchaeology, Roman commoners frequently enjoyed dining on thrushes—small songbirds once thought to be a luxury dish. Birds were prominent figures in ancient Rome. Certain owls and eagles were considered powerful divinatory omens, while smaller avian species like thrushes were popular as both pets and meals. In the latter case, however, ancient texts suggest thrushes were primarily eaten by wealthier Romans. 'Classical sources frequently describe these small birds as a delicacy served in elite banquets, often prepared with elaborate culinary techniques,' the study's authors write. They also cite recipes documented by Pliny the Elder and Apicius that described fattening songbirds with figs before roasting and serving them with complex sauces. These assumptions were recently challenged by finds at an excavation in Mallorca, Spain. There, archeologists from the Mediterranean Institute for Advanced Studies (IMEDEA) uncovered a large cesspit beside a roadside popina snack bar. The building also featured six amphorae (large vats) embedded in its countertop in a configuration like the one seen in Pompeii's famous street food court, or thermopolia. Amid the refuse were 165 thrush bones alongside other common food remains like sea shells as well as fish and pig bones. The condition of the songbirds' broken bones suggest that they were flattened and cooked whole with oil in the amphorae. In addition to the thrushes, archeologists also documented remains from domesticated chickens and European rabbits. These point to a wider menu tailored to everyday customers. Taken altogether, it appears that thrushes were served up similar to today's sports bar chicken wings. The food shop in Mallorca isn't the only example of deep-fried songbirds across Rome. As Arkeonews notes, additional finds in Pompeii and Britain indicates a widespread culture of ancient Roman fast food. 'Thrushes, though a minor component of the Roman diet compared to livestock, represent an important facet of urban food consumption,' the study's authors conclude. 'Ultimately, this research highlights the need to move beyond elite-centric narratives and consider the diverse ways in which food practices shaped the lived experiences of ancient urban communities.'

SpliceBio lands $135M for a new kind of eye gene therapy
SpliceBio lands $135M for a new kind of eye gene therapy

Yahoo

time4 hours ago

  • Yahoo

SpliceBio lands $135M for a new kind of eye gene therapy

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. SpliceBio, a Spanish biotechnology company working on next-generation gene therapies, said Wednesday it raised $135 million in a Series B round to advance its lead program in Stargardt disease into further clinical testing. The startup is built around a technology that's meant to overcome a key limitation of current gene therapies. Scores of gene therapy developers use adeno-associated viruses, or AAVs, to deliver genetic cargo into the body. But because of their small size, AAVs can't carry larger corrective genes, leaving many diseases out of reach or forcing companies to come up with creative solutions. One example is in Duchenne muscular dystrophy. Because of the large size of the gene coding for the muscle-protecting protein dystrophin Duchenne patients lack, several companies, like Sarepta Therapeutics, have developed gene therapies that make a shortened form. The approach comes with drawbacks, however, as a truncated version of the protein might not work as well as the original. SpliceBio has a different workaround. The company is using two separate AAVs to send pieces of a large gene into cells. Once inside, specially engineered splicing molecules help reassemble their cargo into full-length proteins. Stargardt disease, for example, is caused by mutations to the ABCA4 gene, which is too large to stuff into an AAV. SpliceBio says its method can help the body produce a functional version of the protein that gene produces. Its lead program, SB-007, is in a Phase 1/2 trial. SpliceBio isn't the only biotech pursuing this type of approach to treat Stargardt, an inherited eye condition that causes progressive vision loss. Another European company, AAVantgarde, has a similar type of program in early-stage testing. SpliceBio's technology is based on research conducted at Princeton University, where co-founder and CEO Miquel Vila-Perelló was studying protein design and engineering. Launched in 2014 under the name ProteoDesign, the biotech is also working on additional programs in ophthalmology, neurology and other undisclosed therapeutic areas. Its Series B round was co-led by EQT Life Sciences and Sanofi Ventures, and involved seven other backers including Roche Venture Fund, New Enterprise Associates and Novartis Venture Fund. "The support from such high-quality investors underscores the strength of our programs and our unique protein splicing platform and its potential to unlock gene therapies for diseases that remain untreatable today,' Vila-Perelló said in a statement. The company raised €50 million in a Series A round in 2022. Gene and cell therapy startups backed by the roughly two dozen investment firms BioPharma Dive tracks have secured a little over $1.1 billion in venture dollars so far in 2025. Half of those fundings have come in the form of 'megarounds' exceeding $100 million apiece, continuing an ongoing trend. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Experts encourage innovative method to combat invasive fish devastating local ecosystems: 'It's a real natural, sustainable solution'
Experts encourage innovative method to combat invasive fish devastating local ecosystems: 'It's a real natural, sustainable solution'

Yahoo

time7 hours ago

  • Yahoo

Experts encourage innovative method to combat invasive fish devastating local ecosystems: 'It's a real natural, sustainable solution'

Invasive tilapia have been threatening endangered cod populations in Australia's Mary River, but experts say the cod are biting back, the Australian Broadcasting Corp. reported. Conservationists from Burnett Mary Regional Group performed a routine survey in April, which involved catching and testing some of the region's Mary River cod. Researchers were pleased to discover traces of tilapia in two of the cods' mouths and also documented an 80-centimeter (31.5-inch) cod eating a 40-cm (15.75-in) tilapia. In other words, despite the fact that the tilapia are not native to the area and the cod haven't evolved to eat them, the endangered native fish have adapted and are eating them anyway. "There was always the hope and suspicion that [the cod] were eating everything," BMRG CEO Tom Espinoza said. "It's provided a lot of hope for people that are invested in healthy cod populations across the board. … Hopefully in 10, 15, 20 years' time, we've got a population of large cod that can do the rest of the job themselves. It's a real natural, sustainable solution." This is encouraging news, because as matters stand, the tilapia are a serious problem. They're invasive — meaning they came to the area from another region and thrived so well that it's damaging the ecosystem — and they eat the eggs and young of not only cod but also other endangered species such as the "bum-breathing" Mary River turtle, Australian lungfish, and white-throated snapping turtle. Because the tilapia have spread to 26 of Queensland's 67 catchments, it's considered impossible for humans to eradicate them. Left unchecked, they could destroy the native species in the river, damaging the ecosystem that both people and wildlife rely on. However, steps have been taken to control the population. For example, tilapia are being harvested to use as fertilizer for native plants. Now that it appears cod are also eating the tilapia, there's a chance to achieve a new healthy balance. Should we be actively working to kill invasive species? Absolutely It depends on the species I don't know No — leave nature alone Click your choice to see results and speak your mind. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store